Clinical Trials Directory

Trials / Unknown

UnknownNCT03775018

TAP Blockade for Pain Control in One-Anastomosis Gastric Bypass

Transversus Abdominis Plane (TAP) Blockade as Multimodal Analgesia for Pain Control in One-Anastomosis Gastric Bypass (OAGB)

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
140 (estimated)
Sponsor
Hospital General Universitario Elche · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patients will be randomized into 2 groups: * TAP: Patients undergoing TAP blockade, associated with intravenous Acetaminophen analgesia * IV: Patients receiving only intravenous Acetaminophen analgesia Postoperative pain 24 hours after surgery will be evaluated.

Detailed description

Patients will be randomized into 2 groups: * TAP: Patients undergoing TAP blockade, associated with intravenous Acetaminophen analgesia (1g/6h) * IV: Patients receiving only intravenous Acetaminophen analgesia (1g/6h) Postoperative pain 24 hours after surgery will be evaluated, by a Visual Analogic Scale (VAS), ranging from 0 to 100mm.

Conditions

Interventions

TypeNameDescription
PROCEDURETransversus abdominis plane blockadePatients will undergo Transversus abdominis plane blockade with Bupivacaine 0.25% 30ml, applied in the plane between the internal oblique muscle and the trasnversus abdominis. The injection will be performed laterally to the port-sites, bilaterally at the same levels.
DRUGIntravenous analgesiaAcetaminophen 1g/6h iv will be administered

Timeline

Start date
2018-12-13
Primary completion
2019-04-30
Completion
2019-04-30
First posted
2018-12-13
Last updated
2018-12-13

Source: ClinicalTrials.gov record NCT03775018. Inclusion in this directory is not an endorsement.